News
Hosted on MSN7mon
New CML Approval: Leading Leukemia Expert on the ‘Significant Improvement’ Asciminib (Scemblix) Offers Patients as a First-Line Treatment Option - MSNFor chronic myeloid leukemia (CML) patients, there is a promising new first-line drug approval that, according to one of the world’s leading leukemia experts, is showing “significant ...
A panel of experts on chronic myeloid leukemia have a comprehensive discussion on patient-centered care and the important role of shared decision-making in the optimal treatment of patients with CML.
Michael J. Mauro, MD, leader of the Myeloproliferative Neoplasms Program, Leukemia Service, at Memorial Sloan Kettering Cancer Center, discusses the current understanding of TKI discontinuation ...
Similar News Stories. NVIDIA says its AV1 video encoding on GeForce is better than AMD and Intel; Apple's iPhone 15 Pro Max is a camera trendsetter, analyst says, and others will follow ...
CML HealthCare Inc. , a leading community-based provider of laboratory and medical imaging services in Ontario and British Columbia, is pleased to announce that Canada's largest, automated ...
Bio-Rad launches new digital PCR system and kit for monitoring treatment response in CML patients Download PDF Copy Reviewed by James Ives, M.Psych. (Editor) Feb 15 2019 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results